诺和诺德：“减肥神药 ”司美能缓解糖尿病人心衰症状

华尔街见闻04-08

进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。诺和诺德公司推出的热门减肥药物Wegovy（司美格鲁肽）在最新的大型临床试验中显示，对于患有糖尿病的心力衰竭患者，能有效缓解相关症状。这进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。《新英格兰医学杂志》上周六发表的研究报告称，与接受安慰剂对照组相比，使用Wegovy的患者感到疲劳程度明显降低，腿部肿胀减轻，呼吸更加顺畅，且6分钟步行测试...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2425962846?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/dcf8a1229dadd3b3d70f9b42478fc942","is_english":false,"pubTime":"2024-04-08 08:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2425962846","market":"us","top_or_hot":-1,"title":"诺和诺德：“减肥神药 ”司美能缓解糖尿病人心衰症状","media":"华尔街见闻","content":"<div>\n<p>进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。诺和诺德公司推出的热门减肥药物Wegovy（司美格鲁肽）在最新的大型临床试验中显示，对于患有糖尿病的心力衰竭患者，能有效缓解相关症状。这进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。《新英格兰医学杂志》上周六发表的研究报告称，与接受安慰剂对照组相比，使用Wegovy的患者感到疲劳程度明显降低，腿部肿胀减轻，呼吸更加顺畅，且6分钟步行测试...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3712122\">网页链接</a>\n\n</div>\n","source":"wallstreetcn_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德：“减肥神药 ”司美能缓解糖尿病人心衰症状</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德：“减肥神药 ”司美能缓解糖尿病人心衰症状\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-08 08:15 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3712122><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。诺和诺德公司推出的热门减肥药物Wegovy（司美格鲁肽）在最新的大型临床试验中显示，对于患有糖尿病的心力衰竭患者，能有效缓解相关症状。这进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。《新英格兰医学杂志》上周六发表的研究报告称，与接受安慰剂对照组相比，使用Wegovy的患者感到疲劳程度明显降低，腿部肿胀减轻，呼吸更加顺畅，且6分钟步行测试...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3712122\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"https://wallstreetcn.com/articles/3712122","article_id":"2425962846","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/dcf8a1229dadd3b3d70f9b42478fc942"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2425962846","pubTimestamp":1712535310,"sourceInfo":{"source_id":"wallstreetcn_hot_news","name":"华尔街见闻"},"weMediaInfo":null,"summary":"进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NVO":"诺和诺德","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4007":"制药","BK4532":"文艺复兴科技持仓"},"translate_title":"Novo Nordisk: Simei, a \"weight loss medicine\", can relieve the symptoms of heart failure in diabetic patients","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/f1674da70ed8dc73c167e8850a8e1616","symbols_score_info":{"NVO":1},"content_text":"进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。诺和诺德公司推出的热门减肥药物Wegovy（司美格鲁肽）在最新的大型临床试验中显示，对于患有糖尿病的心力衰竭患者，能有效缓解相关症状。这进一步支持了Wegovy用于治疗与肥胖相关疾病的潜力。《新英格兰医学杂志》上周六发表的研究报告称，与接受安慰剂对照组相比，使用Wegovy的患者感到疲劳程度明显降低，腿部肿胀减轻，呼吸更加顺畅，且6分钟步行测试的距离更远。此外，这组患者报告了更少的严重健康问题。该研究是诺和诺德公司推进的一系列大型试验中的最新成果之一，旨在验证Wegovy对于治疗包括膝关节炎、心血管疾病等多种与肥胖相关的健康问题的效果。诺和诺德希望利用这些研究成果，争取让关注成本的保险公司承担这个月成本约为1350美元的药物费用。本周发表的心力衰竭研究聚焦于“有保留射血分数的心力衰竭”——一种心脏的下腔室未能向身体泵送足够血液的情况。在美国，大约有300万人受此症状影响，全球患者数量则可能高达3200万。据JAMA医学杂志去年的一项综述，该疾病的年死亡率约为15%。诺和诺德在今年1月发布第四季度财报时首次公布了心力衰竭研究的初步结果。本次试验针对的是肥胖但非糖尿病的心力衰竭患者。两项试验的结果已于一月份提交给美国和欧洲的监管机构审查。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2425962846"}